Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019

Dimitri Aubert's Biography



Dimitri Aubert, VP Sales and Marketing, Managing Director Europe, NanoFCM

Dimitri Aubert (PhD) is Vice-President Sales & Marketing and Managing Director for Europe at NanoFCM.

He obtained his first degree and MSc in Chemistry from the University of Caen, France, and in 2014 he graduated with a PhD degree in Chemistry from the University of Nottingham, UK, with a project titled synthesis of an epimer of biotin and to the study of its binding affinity for avidin and streptavidin. He started his career in scientific business development at LC Services and Micropump UK, part of IDEX corporation. He then was European Sales Manager at innovative Raman spectroscopy companies from 2008 (Ahura Scientific, now part of Thermo Fisher and at Cobalt Light Systems, now part of Agilent).

Joining Izon Science Ltd in July 2011 as a Director EMEA, and subsequently as Global Director for Sales and Marketing, he helped spreading the usage of instrumentation based on resistive pulse sensing for extracellular-vesicles measurement.

Starting at NanoFCM in 2018, he is overseeing the international development of Nano-Flow Cytometry, the next-generation technology for extracellular vesicles analysis, which offers powerful and quantitative phenotyping capabilities.

Dimitri Aubert Image

Nano-Flow Cytometry: Next-Generation Platform for Comprehensive EV Analysis

Wednesday, 30 October 2019 at 17:45

Add to Calendar ▼2019-10-30 17:45:002019-10-30 18:45:00Europe/LondonNano-Flow Cytometry: Next-Generation Platform for Comprehensive EV AnalysisCirculating Biomarkers, Exosomes and Liquid Biopsy Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Though of great importance, sizing and molecular profiling of individual extracellular vesicles (EVs) are technically challenging due to their nanoscale particle size, minute quantity of analytes, and overall heterogeneity. NanoFCM has developed Nano-Flow Cytometry (nFCM), a technology that allows light scattering and fluorescence detection of single EVs down to 40 nm. nFCM-based approach for quantitative multiparameter analysis of EVs, which is highly desirable to decipher their biological functions and promote the development of EV-based liquid biopsy and therapeutics.


Add to Calendar ▼2019-10-30 00:00:002019-11-01 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Europe 2019Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com